Will Nicotine Genetics and a Nicotine Vaccine Prevent Cigarette Smoking and Smoking-Related Diseases?

Hall argues that the preventive use of genetic and vaccine biotechnologies is a superficially attractive tobacco policy option of doubtful efficacy, cost-effectiveness, and ethicality.

Detalles Bibliográficos
Autor principal: Hall, Wayne D
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2005
Materias:
Research in Translation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236791/
https://www.ncbi.nlm.nih.gov/pubmed/16173831
http://dx.doi.org/10.1371/journal.pmed.0020266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1236791/
https://www.ncbi.nlm.nih.gov/pubmed/16173831
http://dx.doi.org/10.1371/journal.pmed.0020266

Ejemplares similares